Long‐Term Outcomes of Omniflow II and BioIntegral Xenografts for Open Aortic Reconstruction in Predominantly Infected Settings: A Multicenter Cohort Study
Tijmen W. Kraai, Eline I. Reinders Folmer, Barzi Gareb, David J. Liesker, Ben R. Saleem, Clark J. Zeebregts, Vascular Xenograft Research Group · 2026
Read Long‐Term Outcomes of Omniflow II and BioIntegral Xenografts for Open Aortic Reconstruction in Predominantly Infected Settings: A Multicenter Cohort Study by Tijmen W. Kraai, Eline I. Reinders Folmer, Barzi Gareb, David J. Liesker, Ben R. Saleem, Clark J. Zeebregts, Vascular Xenograft Research Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13662509.txt.
Description
Tijmen Kraai and co-authors report a 2026 study of long-term results after major aorta repair using grafts made from animal tissue. When the aorta must be rebuilt in a place with infection, picking the right graft is hard, and proof on these tissue grafts is thin. The patients in the study could not have their own vein used for the repair.
The study joins records from six Dutch hospitals with a registry kept going forward in time. It covers open repairs of the aorta and its nearby branches done between 2014 and 2021, mostly where infection was present. Two graft types are compared: a bovine graft and a biosynthetic one. The authors track how patients fared over the long term, giving surgeons rare side-by-side data for a tough choice.
Catalog record
| CREATOR | Tijmen W. Kraai, Eline I. Reinders Folmer, Barzi Gareb, David J. Liesker, Ben R. Saleem, Clark J. Zeebregts, Vascular Xenograft Research Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |